Oral, esophageal and head/neck cancer is the sixth most common cancer worldwide with a global annual incidence of 500,000. This group of cancer is a heterogeneous group of cancers, with a variable, but usually poor prognosis in patients. Besides the poor outcome, head and neck cancer has a great impact on the patient’s quality of life, due to its anatomic location.
Professor Lam’s research studies the group of cancers by animal experiments, cell line cultures, gene profiling and clinicopathological correlations in order to understand the biological behaviour and to reveal the underlying mechanisms of cancer progression and therapy resistance.